Clinical limitations of risk assessment models

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6 SUPPL. 2, 1999, Pages

  Lassen, M R ^a   Borris, L C ^b   Backs, S ^b   Kaltoft Sorensen M ^b   Coff Ganes, H ^b   Jeppesen, E ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

Deep vein thrombosis; Low molecular weight heparins; Pulmonary embolism; Risk assessment models; Risk factor indices; Thromboprophylaxis; Unfractionated heparin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

DISEASE MANAGEMENT; HUMANS; PULMONARY EMBOLISM; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0032857899     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Nicolaides AN, Bergqvist D, Hull R, Ackchurin RS, Allegra C, Arcelus J, et al. Consensus Statement: prevention of venous thromboembolism. Int Angiol 1997; 16: 3-38.
2. Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995; 108 (suppl): 312S-334S.
3. Bergqvist D, Jendteg S, Lindgren B, Matsch T, Persson U. The economics of general thromboprophylaxis. World J Surg 1988; 12: 349-355.
4. Flordal PA, Bergqvist D, Burmark U-S, Ljungstrom K-G, Torgren S, for the Fragmin Multicentre Study Group. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. Eur J Surg 1996; 162: 783-789.
5. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccidi A, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82: 423-428.
6. Bergqvist D, Matsch T, Jenteg S, Lindgren B, Persson U. The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir Scand 1990; 556 (suppl): 36-41.
7. Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopaedic surgery. JAMA 1987; 257: 203-208.
8. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism. Analysis of cost effectiveness. Ann Surg 1980; 191: 207-218.
9. Borris LC, Lassen MR. Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost-effective. Drugs 1996 52 (suppl 7): 42-46.
10. Gensini GF, Prisco D, Falciani M, Comeglio M, Colella A. Identification of candidates for prevention of venous thromboembolism. Semin Thromb Hemost 1997; 23: 55-67.
11. Brandjes DPM, ten Cate JW, Buller HR. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. Acta Chir Scand 1990; 556 (suppl): 18-21.
12. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-574.
13. Storti S, Crucitti P, Cina G. Risk factors and prevention of venous thromboembolism. RAYS 1996; 21: 439-460.
14. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. Arch Surg 1992; 127: 310-313.
15. Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974; 81: 311-316.
16. Cofrancesco K, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery. Thromb Haemost 1997; 77: 267-269.
17. Hoek JA, Nurmohamed MT, ten Cate JW, Buller HR, Knipscheer HC, Hamelynck KJ, et al. Thrombin-antithrombin complexes in the prediction of deep vein thrombosis following total hip replacement. Thromb Haemost 1989; 62: 1050-1052.
18. Bongard O, Wicky J, Peter R, Simonovska S, Vogel J-J, de Moerloese P, et al. D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res 1994; 74: 487-493.
19. Nieuwenhuizen W. Plasma assays for derivatives of fibrin and fibrinogen based on monoclonal antibodies. Fibrinolysis 1988; 2: 1-5.
20. Clayton JK, Anderson JA, McNicol GP. Pre-operative prediction of postoperative deep vein thrombosis: BMJ 1976; 16: 910-912.
21. Lowe GDO, Osborne DH, McArdle BM, Smith A, Carter DC, Forbes CD, et al. Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet 1982; i: 409-412.
22. Sue-Ling HM, Johnston D, McMahon MJ, Philips PR, Davies JA. Pre-operative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery. Lancet 1986; i: 1173-1176.
23. Gallus AS, Hirsh J, Gent M. Relevance of pre-operative and post-operative blood tests to post-operative leg-vein thrombosis. Lancet 1973; ii: 805-809.
24. Kakkar V, Howe C, Nicolaides A, Renney JTC, Clarke MR. Deep vein thrombosis of the leg: is there a high risk group? Am J Surg 1970; 20: 527-530.
25. Comité Scientifique Thrombose de l'APHP. Prophylaxie de thromboses veineuses postopératoires: recommandations de l'Assistance publique-Hôpitaux de Paris. Sang Thromb Vaiss 1995; 7: 119-120.
26. Haas S. Risikoabschätzung thromboembolischer Komplikationen bei chirurgischen Erkrankungen und Verletzungen. Akt Chir 1996; 31: 269-275.
27. Salzman EW, Hirsh J. Prevention of venous thromboembolism. In: Colman RW, Hirsh J, Mardet V, Salzman EW (editors). Hemostasis and thrombosis: basic principles and clinical practice. New York: Lippincott, 1982; 986.
28. Crandon AJ, Peel KR, Anderson JA, Thompson V, McNicol GP. Prophylaxis of postoperative deep vein thrombosis: selective use of low-dose heparin in high risk patients. BMJ 1980; 2: 345-347.
29. Racoczi I, Chamone D, Collen D, Verstraete H. Prediction of postoperative leg-vein thrombosis in gynaecological patients. Lancet 1978; i: 509-510.
30. Eriksson BI, Wille-Jorgensen P, Kalebo P, Mouret P, Rosencher N, Bosch P, et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997; 337: 1329-1335.